Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.
E RamírezB PicatosteA González-BrisM OteoF CruzA Caro-VadilloJ EgidoJ TuñónM A MorcilloÓscar LorenzoPublished in: Cardiovascular diabetology (2018)
Besides of its anti-hyperglycemic effect, sitagliptin-enhanced GLP-1 may ameliorate diastolic dysfunction in type-II diabetes by shifting fatty acid to glucose utilization in the cardiomyocyte, and thus, improving cardiac efficiency and reducing lipolysis.